Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06672159

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

Led by St. Olavs Hospital · Updated on 2025-06-05

356

Participants Needed

1

Research Sites

178 weeks

Total Duration

On this page

Sponsors

S

St. Olavs Hospital

Lead Sponsor

N

Norwegian Air Ambulance Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

Double Sequential External Defibrillation (DSED) represents an alternative treatment of refractory ventricular fibrillation (rVF) in out-of-hospital cardiac arrest (OHCA). The procedure consists of two defibrillators that administer shocks at the same time. Currently, the procedure is not initiated before at least three failed attempts with one defibrillator. This can delay the potential benefits of establishing DSED earlier in the treatment. Studies have shown that early defibrillation is crucial for survival in OHCA patients, and in 2022, a clinical trial showed that survival in patients treated with DSED was higher compared to standard treatment. The effect of initiating OHCA treatment is unknown. The DUALDEFIB trial seeks to investigate if treating OHCA patients with DSED as an initial treatment will increase survival and provide improved neurological outcome.

CONDITIONS

Official Title

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with out of hospital cardiac arrest presenting with a shockable rhythm
Not Eligible

You will not qualify if you...

  • Age below 18 years
  • Obvious or suspected pregnancy
  • Incarcerated patients
  • Preexisting do-not-resuscitate order

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St Olavs Hospital

Trondheim, Norway, 7030

Actively Recruiting

Loading map...

Research Team

J

Jostein R Brede, MD

CONTACT

V

Vegard Nordviste, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here